v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 4,846 $ 4,422
Accounts receivable, net 2,993 1,698
Inventories 2,906 2,015
Insurance recoveries 9,500 768
GVB promissory note, net   500
Prepaid expenses and other current assets 2,678 1,068
Current assets of discontinued operations held for sale 0 1,051
Total current assets 22,923 11,522
Property, plant and equipment, net 2,452 2,773
Operating lease right-of-use assets, net 767 1,639
Intangible assets, net 6,210 5,724
Other assets 15 15
Total assets 32,367 21,673
Current liabilities:    
Notes and loans payable - current 368 254
Current portion of long-term debt   1,500
Operating lease obligations 163 261
Accounts payable 2,598 2,401
Accrued expenses 2,234 1,021
Accrued litigation   768
Accrued payroll 140 318
Accrued excise taxes and fees 3,399 2,038
Deferred income 79 20
Other current liabilities 1,231 100
Current liabilities of discontinued operations held for sale 333 1,281
Total current liabilities 10,545 9,962
Long-term liabilities:    
Operating lease obligations 644 1,437
Long-term debt   5,165
Other long-term liabilities 74 1,097
Total liabilities 11,263 17,661
Commitments and contingencies (Note 12)
Mezzanine Equity    
Series A convertible preferred shares, $0.00001 par value; 9,650 shares issued and outstanding at September 30, 2025 and 0 at December 31, 2024, respectively 2,734  
Total mezzanine equity 2,734  
Shareholders' equity:    
Common stock, par value
Capital in excess of par value 414,487 397,883
Accumulated deficit (396,117) (393,871)
Total shareholders' equity 18,370 4,012
Total liabilities, mezzanine equity and shareholders' equity 32,367 21,673
Series A Convertible    
Mezzanine Equity    
Series A convertible preferred shares, $0.00001 par value; 9,650 shares issued and outstanding at September 30, 2025 and 0 at December 31, 2024, respectively $ 2,734